InvestorsHub Logo
Followers 5
Posts 467
Boards Moderated 0
Alias Born 05/03/2005

Re: None

Tuesday, 02/26/2019 4:53:12 PM

Tuesday, February 26, 2019 4:53:12 PM

Post# of 113733
ZYXI ($5.40) beat their guidance on revenue up 15% yoy for the quarter 36% yoy for the year. EBITDA came in at low end of their guidance because they have been aggressively increasing salesforce.

http://zynexmed.investorroom.com/2019-02-26-Zynex-Announces-2018-Fourth-Quarter-and-Full-Year-Earnings

Zynex Announces 2018 Fourth Quarter and Full Year Earnings
2018 Full Year
- Revenue increased 36% year over year to $31.9 million
- Net income increased 30% to $9.6 million; Diluted EPS $0.28
- Adjusted EBITDA $10.9M
2018 Fourth Quarter
- Revenue increased 15% year over year to $9.3 million
- Net income of $2.6 million; Diluted EPS $0.08
- Adjusted EBITDA $3.1 million
- Tenth consecutive quarter of positive net income
Listed on The Nasdaq Capital Market effective February 12, 2019


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.